AbbVie ABBV Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $9.39B+81.5% | $5.23B-5.3% | $5.63B-22.4% | $6.47B-50.7% | $5.18B-71.4% | ||
| $12.48B0.0% | $12.59B+15.3% | $12.77B+11.3% | $12.64B+7.8% | $12.48B+4.4% | ||
| $5.05B+11.6% | $4.95B+18.4% | $4.94B+11.0% | $4.96B+17.6% | $4.53B+6.6% | ||
| $1.11B-0.5% | $1.08B+2.6% | $1.08B+4.8% | $1.17B+6.1% | $1.11B+1.3% | ||
| $2.14B+8.3% | $2.29B+17.2% | $2.28B+9.9% | $2.11B+9.5% | $1.97B+4.4% | ||
| $150M-97.3% | $6.27B+27.2% | $5.16B+12.7% | $5.2B+10.2% | $5.5B+19.3% | ||
| $33.53B+21.2% | $29.06B+13.6% | $28.54B+2.7% | $29.26B-13.5% | $27.68B-28.8% | ||
| $5.69B+8.6% | $5.63B+9.6% | $5.48B+6.7% | $5.28B+5.2% | $5.24B+5.2% | ||
| $8.04B+9.7% | $7.9B+10.8% | $7.75B+8.5% | $7.65B+11.2% | $7.33B+8.7% | ||
| $35.57B+0.8% | $35.64B+2.0% | $35.63B+0.9% | $35.64B+6.7% | $35.29B+5.6% | ||
| $137M-94.7% | $2.39B-7.4% | $2.48B-9.8% | $2.55B-6.3% | $2.58B-5.1% | ||
| $136.46B+0.2% | $133.96B-0.9% | $133.9B-6.6% | $137.18B-3.4% | $136.17B-8.5% | ||
| $0-100% | $2.5B— | $3.79B-69.8% | $5.56B-55.9% | $1.59B+53,000% | ||
| —— | $19M+11.8% | —— | —— | —— | ||
| $0-100% | $2.5B— | $3.79B— | $5.56B— | $1.59B+53,000% | ||
| $42.1B+15.6% | $43.29B+11.7% | $39.39B-8.5% | $39.77B-5.1% | $36.4B-12.3% | ||
| $34.11B+9.4% | $32.57B+8.1% | $31.66B-4.2% | $32.04B-1.2% | $31.19B-4.8% | ||
| $18M0.0% | $18M0.0% | $18M0.0% | $18M0.0% | $18M0.0% | ||
| -$17.87B-87.6% | -$15.49B-96.1% | -$14.23B-187% | -$11.5B-205% | -$9.53B-300% | ||
| -$1.15B+33.8% | -$1.14B+40.6% | -$1.57B+32.6% | -$1.54B+38.8% | -$1.74B+29.0% | ||
| -$6.66B-569% | -$3.27B-198% | -$2.64B-144% | -$183M-103% | $1.42B-82.3% | ||
| $136.46B+0.2% | $133.96B-0.9% | $133.9B-6.6% | $137.18B-3.4% | $136.17B-8.5% | ||
| $1.81B+25.3% | $1.58B+34.7% | $1.58B+17.2% | $1.68B+41.4% | $1.44B+14.5% | ||
| $6.61B+20.3% | $6.29B+27.7% | $5.16B+12.7% | $5.2B+10.2% | $5.5B+19.3% | ||
| $155M+19.2% | $91M-70.9% | $125M+184% | $101M-47.4% | $130M+31.3% | ||
| $163M+3.8% | $159M-5.9% | $172M+12.4% | $166M+3.8% | $157M-2.5% | ||
| $10.54B+14.6% | $10.72B+17.3% | $9.64B+16.4% | $9.66B+5.0% | $9.19B+1.4% | ||
| $163M+3.8% | $159M-5.9% | $172M+12.4% | $166M+3.8% | $157M-2.5% | ||
| $5.27B-0.4% | $5.28B+1.5% | $5.28B-45.5% | $5.29B+235% | $5.29B+235% | ||
| $5.27B-0.4% | $5.28B+1.5% | $5.28B-45.5% | $5.29B+235% | $5.29B+235% | ||
| $5.27B-0.4% | $5.28B+1.5% | $5.28B-45.5% | $5.29B+235% | $5.29B+235% | ||
| $163M+3.8% | $159M-5.9% | $172M+12.4% | $166M+3.8% | $157M-2.5% | ||
| $45.6B-14.3% | $47.36B-13.7% | $49.03B-13.9% | $51.75B-11.8% | $53.2B-12.3% | ||
| $50.87B-13.0% | $52.64B-12.4% | $54.32B-18.5% | $57.03B-5.3% | $58.49B-6.0% | ||
| $268M-6.6% | $268M-3.9% | $291M+9.0% | $310M+14.0% | $287M-5.9% | ||
| $10.54B+14.6% | $10.72B+17.3% | $9.64B+16.4% | $9.66B+5.0% | $9.19B+1.4% | ||
| $13.73B+9.2% | $13.53B+10.3% | $13.23B+7.7% | $12.93B+8.7% | $12.57B+7.2% | ||
| $10.54B+14.6% | $10.72B+17.3% | $9.64B+16.4% | $9.66B+5.0% | $9.19B+1.4% | ||
| $33.77B+8.8% | $34.73B+8.7% | $33.62B+10.3% | $32.25B+9.9% | $31.04B-0.9% | ||
| $8.33B+121% | $6.06B-11.0% | $1.98B-84.2% | $1.97B-84.4% | $3.77B-63.0% | ||
| $338M+34.1% | $540M+103% | $690M+54.7% | $880M+158% | $252M-41.1% | ||
| $64.53B0.0% | $58.94B-2.3% | $62.97B+7.6% | $62.96B+8.5% | $64.53B+1.1% | ||
| —— | $62.36B+1.8% | $66.76B-6.1% | $68.52B-3.0% | $66.12B+3.6% | ||
| $22.96B+5.3% | $22.5B+5.4% | $22.29B+5.3% | $21.99B+5.3% | $21.81B+5.6% | ||
| $10.61B+16.1% | $9.15B+11.5% | $9.14B+16.5% | $9.15B+16.7% | $9.14B+16.7% | ||
| $1.8B-37.9% | —— | $2.9B-25.6% | $2.9B-25.6% | $2.9B-25.6% | ||
| $1M-99.0% | —— | -$36M— | -$8M— | $105M— | ||
| $13.73B+9.2% | $13.53B+10.3% | $13.23B+7.7% | $12.93B+8.7% | $12.57B+7.2% | ||
| $338M+34.1% | $540M+103% | $690M+54.7% | $880M+158% | $252M-41.1% | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| 4B0.0% | 4B0.0% | 4B0.0% | 4B0.0% | 4B0.0% | ||
| 1.8B+0.4% | 1.8B+0.4% | 1.8B+0.4% | 1.8B+0.4% | 1.8B+0.4% | ||
| $2.33B-9.7% | $2.39B-7.4% | $2.48B-9.8% | $2.55B-6.3% | $2.58B-5.1% | ||
| $155M+19.2% | $91M-70.9% | $125M+184% | $101M-47.4% | $130M+31.3% | ||
| $338M+34.1% | $540M+103% | $690M+54.7% | $880M+158% | $252M-41.1% | ||
| $163M+3.8% | $159M-5.9% | $172M+12.4% | $166M+3.8% | $157M-2.5% | ||
| $27.04B+19.0% | $25.37B+17.1% | —— | —— | $22.71B— | ||
| —— | $19M+11.8% | —— | —— | —— | ||
| $43.92B+19.4% | $42.23B+21.1% | $40.45B+22.2% | $38.76B+24.4% | $36.79B+23.1% | ||
| $89.52B-0.5% | $89.59B-0.2% | $89.48B-0.6% | $90.5B+0.8% | $89.99B-0.6% | ||
| $5.27B-0.4% | $5.28B+1.5% | $5.28B-45.5% | $5.29B+235% | $5.29B+235% | ||
| $94.8B-0.5% | $94.87B-0.1% | $94.76B-5.0% | $95.79B+4.8% | $95.28B+3.4% | ||
| $1.7B-5.6% | $1.6B-36.0% | $1.5B-37.5% | $1.8B— | $1.8B— | ||
| $64.53B0.0% | $58.94B-2.3% | $62.97B+7.6% | $62.96B+8.5% | $64.53B+1.1% | ||
| $8.33B+121% | $6.06B-11.0% | $1.98B-84.2% | $1.97B-84.4% | $3.77B-63.0% | ||
| $44M+4.8% | $42M+7.7% | $43M+10.3% | $45M+4.7% | $42M+5.0% | ||
| $1.8B-37.9% | —— | $2.9B-25.6% | $2.9B-25.6% | $2.9B-25.6% | ||
| $23M+9.5% | —— | $21M— | $21M— | $21M— | ||
| 77.1M+8.9% | 70.8M+6.7% | 70.8M+10.1% | 70.8M+10.2% | 70.8M+10.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are AbbVie's total assets?
- AbbVie (ABBV) holds $136.46B in total assets, up 0.2% year over year.
- How much cash does AbbVie have?
- AbbVie holds $9.4B in cash and equivalents.
- Can AbbVie cover its short-term obligations?
- Its current ratio is 0.80 — current liabilities exceed current assets.
- Where does AbbVie's balance sheet data come from?
- Every line is extracted from AbbVie's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
